RE:RE:RE:BREXAFEMME - published User side effects I was going to sell at a loss, but decided to lower my average cost due to the discount. They will have $150M cash less Q1 spend. Probably trading at 70% current cash with an approved blockbuster drug in sales mode. New cash is either due to slow sales ramp or accelerated new programs. Management does not care about the SP which means retail will get fleeced more but I am hopeful this might be the end of the incompetent financings. Heads do need to roll here. Mario cannot remain on charge of the business side, and if he expects to then he owes shareholders an explanation, and why do some shareholders get treated differently than others. SEC should investigate Mario since clearly information is being shared with a selective audience.